Will Legal Weed Stop the Opioid Crisis?

States that have medical marijuana see a 20% drop in opioid prescriptions.

Trouble viewing this e-mail? Click here to read it online      Will Legal Weed Stop the Opioid Crisis? By Ian Wyatt | June 30, 2020 46,802.   That's how many people died from opioid use in just one year.   Yet the crisis may be improving – thanks to legalization of cannabis.   Go here for my #1 Pot Stock pre-IPO (BEFORE it goes public in July).   A new study from Columbia University in New York shows that cannabis can help reduce opioid deaths.   States that have medical marijuana see a 20% drop in opioid prescriptions.   That means doctors are now willing to prescribe cannabis for pain management. And patients may be requesting cannabis instead of highly addictive opioids.   The study found that medical marijuana reduced the prescribing of 144,000 daily opioid doses.   It's clear that states with medical marijuana programs are better positioned to overcome the opioid crisis.   The good news is that cannabis is going mainstream across America (go here for my #1 pot stock for 733% profits).   Check out these poll results from the Pew Research Center: 91% say medical marijuana should be legal 59% say recreational marijuana should be legal 55% of Republicans support full legalization 78% of Democrats support full legalization That's right…   Nine out of every 10 Americans wants medical marijuana to be legal!   Federal laws still classify cannabis as ILLEGAL.   Yet that hasn't stopped 33 states from legalizing medical marijuana. And another 11 states have legalized adult recreational use.   Voters in another nine states could legalize cannabis in November. That's just one reason the sector is soaring recently.   In fact, gains for the cannabis ETF have outperformed the S&P 500 by 2-to-1.     This sector is growing like crazy. And stocks are already taking off. Yet one undiscovered pot stock is still super cheap. In fact, early investors can grab private Pre-IPO shares for just $0.25.   Unlike most private stocks – this one is expected to go public within four weeks.   That means you could quickly BUY shares today for just $0.25. And within a few weeks, shares could be listed in Canada and the U.S.   The price? There's no certainty here. Yet I wouldn't be surprised to see the stock quickly double or triple in price.   Plus, my longer-term price target suggests 733% upside potential.   Click here for urgent details on the brand-new cannabis boom. Plus, you'll discover next steps for grabbing Pre-IPO shares. Yours in Wealth,   Ian Wyatt If you have any questions about your subscription, please contact Customer Care at 866-447-8625 or 802-448-8410. Monday - Friday between 9:00 a.m. and 5:00 p.m. ET   Wyatt Investment Research | 65 Railroad Street | Richmond, VT 05477 USA Toll Free: 866-447-8625 or International: 802-448-8410 Web Site: www.wyattresearch.com Email Customer Service: customerservice@wyattresearch.com   Disclaimer & Important Information WyattResearch.com is owned and published by Wyatt Investment Research. Wyatt Investment Research is neither a registered investment adviser nor a broker/dealer. Readers are advised that this electronic publication is issued solely for information purposes and should not to be construed as an offer to sell or the solicitation of an offer to buy any security. If you believe this communication to be a mistake or unsolicited, please forward this email to abuse@wyattresearchnewsletters.com and be sure to include details regarding your situation. We will be sure to promptly investigate your situation and get back to you within 4-7 business days.  Copyright (c) 2020 Wyatt Investment Research. Wyatt Investment Research 65 Railroad Street Richmond, VT 05477 PO Box 790 Terms | Privacy | Email Policy | Compensation | Disclosure  Unsubscribe | Delivery Preferences Click Here to View Our Website Unsubscribe from Market Traders Academy Unsubscribe from ALL of our emails